Ярустовский М. Б., Абрамян М. В., Попок З. В., Назарова Е. И., Ступченко О. С., Попов Д. А., Плющ М. Г., Самсонова Н. Н.

ЛИТЕРАТУРА
1. Гельфанд Б. Р., Руднов В. А., Проценко Д. Н., Гельфанд Е. Б., Звягин А. А., Ярошецкий А. И., Романовский Ю. Я. Сепсис: определение, диагностическая концепция, патогенез и интенсивная терапия. Инфекция в хирургии 2004, т. 2, № 2, 2—17.
2. Bellomo R., Kellum J. A., Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Int. Care Med. 2007, 33: 409—413.
3. Bellomo R., Ronco C., Kellum J. A., Metha R. L., Palevsky P. Acute renal failure — definition, outcome measure, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 2004, 8: R204—R212.
4. Blomquist S., Gustafsson V., Manopolos T., Pierre L. Clinical experience with lipopolysaccharide adsorber in cardiac surgery. Critical Care 2007, 11 (Suppl. 4): P43: 10.1186/cc6022.
5. Bouman C. S., Oudemans-Van Straaten H. M., Tijssen J. G., Zandstra D. F., Kesecioglu J. Effect of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit. Care Med. 2002; 30: 2205—2211.
6. Brun-Buisson C., Meshaka P., Pinton P. et at. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Int Care Med. 2004, 30: 4: 580—588.
7. Casella G., Monti G., Terzi V., Pulici M., Ravizza A., Vesconi S.: Terapie "non-convenzionali" nello shock settico refrattario: esperienza clinica con Polymyxin B. Minerva Anestesiol 2006, 72 (Suppl. 1): 63—67.
8. Cole L., Bellomo R., Hart G. et al. A phase II randomized, controlled trial of continuous Hemofiltration in sepsis. Crit. Care Med, 2002; 30: 1: 100—106.
9. Cruz D. N., Perazella M. A., Bellomo R., Polanco N., Massimo de Cal, Corradi V., Nalesso F., Lentini P., Ueno T., Ranieri M. V., Ronco C. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic Review. Critical Care 2007, 11: R47.
10. Haase M., Bellomo R., Morgera S., Baldwin I., Boyce N. 16th Inter. High cut-off point membranes in septic acute renal failure: a systematic review. Int. J. Artif. Organs. 2007 Dec; 30 (12): 1031—41.
11. Honore P. M., Matson J. R. Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Review. Crit. Care Med. 2002, 6, 394—396.
12. Karlsson S., Varpula M., Ruokonen E., Pettilд V., Parviainen I., Ala-Kokko T. I., Kolho E., Rintala E. M. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007, 33: 435—443.
13. Kellum J. A. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia. Crit. Care Med. 2004, 32: 3; 801—805.
14. Kojika M., Sato N., Yaegashi Y., Suzuki Y., Suzuki K., Nakae H., Sigeatu Endo S.: Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): Evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Therapeutic Apheresis and Dialysis 2006, 10 (1): 12—18.
15. Kushi H., Miki T., Nakahara J., Okamoto K., Saito T., Tanjoh K.: Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif 2006, 24: 212—217.
16. Kushi H., Miki T., Okamoto K., Nakahara J., Saito T., Tanjoh K.: Early haemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit. Care 2005, 9: R653—R661.
17. Martin G. S., Mannino D. M., Eaton S. et al. The epidemoilogy of sepsis in the United States from 1979 through 2000. New Engl. J. Med. 2003; 348: 1546—1554.
18. Monti G. PMX use for endotoxemic critically ill patients. Crit. Care 2008, 12 (Suppl. 2), 134.
19. Nakamura T., Kawagoe Y., Matsuda T., Shoji H., Ueda Y., Tamura N., Ebihara I., Koide H.: Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif 2004, 22: 256—260.
20. Pierre L., Blomqvist S., Ljunggren L., Steen S. Новые медицинские технологии для снижения уровня LPS при экспериментальной эндотоксемии. V международная конференция "Актуальные аспекты экстракорпорального очищения крови в интенсивной терапии" Москва, 2006, стр. 31—32.
21. Raghfan M., Guo R. F., Ward P. A. Novel strategies for the treatment of sepsis. In: Yearbook of Intensive Care and Emergency Medicine 2006, Edt. by J. L. Vincent, p. 68—75.
22. Riedermann N. C., Murray H., Kellum J. A. Fluid resuscitation and immunomodulation in the critically ill. Nat. Med. 2003, 9 (5), 517—524.
23. Ronco C., D’Intini V., Bellomo R., Ricci Z., Bonello M., Ratanarat R., Salvatori G., Bordoni V., Andrikos E., Brendolan A. Обоснование применения экстракорпоральных методов лечения при сепсисе "Анестезиология и реаниматология" 2005, № 2, 87—91.
24. Ronco C. Роль адсорбции при поддержке или замещении функции почек при сепсисе и полиорганной недостаточности. Сборник трудов VI конференции "Актуальные аспекты экстракорпорального очищения крови в ИТ", М., 2008, 11—15.
25. Shoji H. Extracorporeal Endotoxin Removal for the Treatment of Sepsis: Endotoxin Adsorption Cartridge (Toraymyxin). Therapeutic Apheresis and Dialysis 2007 (1): 108—114.
26. Tani T., Hanasawa K., Endo Y., Yoshioka T., Kodama M., Kaneko M., Uchiyama Y., Akizawa T., Takahashi K., Sugai T.: Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin-B immobilized column. Artif. Organs 1998, 22: 1038—44.
27. Tani T., Hanasawa K., Kodama M., Imaizumi H., Yonekawa M., Saito M., Ikeda T., Yagi Y., Takayama K., Amano I., Shimaoka H., Ohta M., Okahisa T., Koga N., Fujita N., Yamase H.: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 in septic patients. World J. Surg. 2001, 25: 660—8.
28. Tojimbara T., Sato S., Nakajima I. et al.: Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure. Therapeutic Apheresis and Dialysis 2004, 8: 286—292.
29. Tsushima K., Kubo K., Koizumi T., Yamamoto H., Fujimoto K., Hora K., Kan-nou Y.: Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J. Clin. Apheresis 2002, 17: 97—102.
30. Uriu K., Osajima A., Kamochi M., Watanabe H., Aibara K., Kaizu K.: Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am. J. Kidney Dis. 2002, 39: 937—947.
31. Uriu K., Osajima A., Kamochi M., Watanabe H., Aibara K., Kaizu K.: The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the absorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock. Therapeutic Apheresis 2001, 5: 25—30.
32. Vincent J., Laterre P., Cohen J., Burchard H., Bruining H., Lerma F., Wittebole X., de Backer D., Brett S., Marzo D., Nakamura H., John S.: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005, 23: 400—405.
33. Yaroustovsky M. B., Gelfand B., Popok Z., Abramyan M., Nazarova E., Yakovleva I., Popov D. A., Plyushtch M. Lipopolysaccatide adsorption in combined therapy of patients with severe sepsis. Crit. care 2008, 12 (Suppl. 2), 178.